You are currently viewing a new version of our website. To view the old version click .

Antimicrobial Resistance in Nosocomial Clinical Microorganisms: from Vitro to Molecular

This special issue belongs to the section “Antimicrobial Agents and Resistance“.

Special Issue Information

Dear Colleagues,

Infectious diseases are the second leading cause of death worldwide and 17 million people die each year from bacterial infections. In Europe, 25,000 people die from drug-resistant infections. In the United States, infections are the fourth most common cause of death, with 2.8 million people infected each year and 35,000 deaths from drug-resistant infections. Multiple mechanisms are involved in the natural and acquired resistance to many of the antimicrobial agents commonly used in clinical practice. Rates of multidrug-resistant infections have increased compared to previous years, especially among nosocomial clinical pathogens.

In this Special Issue, we wanted to address the issue of nosocomial infections caused by multidrug-resistant infectious agents and their pathogenic and virulent mechanisms.

Dr. Matthew Donadu
Dr. Donatella Usai
Prof. Stefania Zanetti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mechanisms of pathogenicity
  • virulence mechanisms
  • new antimicrobial
  • antimicrobial effects
  • clinical applications
  • the antifungal properties
  • antiviral properties
  • antimicrobial mechanisms
  • the combination with other antimicrobials
  • the effects and possible global changes of the human microbiome

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Microorganisms - ISSN 2076-2607